News | News By Subject | News by Disease News By Date | Search News

Influenza News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work     6/23/2016
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines     3/25/2016
Valeant (VRX) Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo     2/3/2016
Visterra, Inc. Awarded Contract Valued at Up to $204.5 Million     10/5/2015
Novartis AG (NVS) Researchers ID Possible Link Between GlaxoSmithKline (GSK) Flu Vaccine, Narcolepsy     7/6/2015
GlaxoSmithKline (GSK) Recalls Flu Vaccine Over Potency Issues     4/21/2015
Why the Flu Vaccine Barely Worked This Year     4/8/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015     2/10/2015
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu     2/2/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)     1/28/2015
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure     12/23/2014
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab     12/22/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax     12/18/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014

News from Around the Web
Why It’s Time For A Rethink On Flu Vaccination     11/21/2016
The $5.8 Billion Hidden Cost Of The Flu On The U.S. Economy     10/31/2016
The Top 4 Flu Treatments That Do Not Work (And 2 That Do)     10/26/2016
Man’s Best Friend May Be The Flu’s Worst Enemy, University of Hong Kong Study     9/30/2016
MedImmune (AZN)'s Flumist Vaccine Just Got Another Thumbs Down. This Time It's A Pediatricians Group     9/13/2016
Interferon Shows Promise As Flu Therapy, Francis Crick Institute in London Study     9/7/2016
Your Weight Could Make The Flu Shot Less Effective, WHO Reveals     8/8/2016
What's Going On With The Nasal FluMist Vaccine? CDC Reveals     6/28/2016
Flu Vaccine May Lower Dementia Risk In Heart Failure Patients, Taipei Medical University Study     5/24/2016
Why It's Better To Get Your Flu Vaccine In The Morning     4/26/2016
Want To Avoid A Cold? Try A Tattoo Or Twenty, Says University Of Alabama Researcher     3/9/2016
Super Bowl Celebrations May Spread Flu, Tulane University Study     2/2/2016
First Flu-Related Death Of Child This Season Reported In Clark Co.     12/31/2015
Prolonged TV Watching Linked To Eight Leading Causes Of Death, American Journal of Preventive Medicine Publishes     10/28/2015
Could A Drug Engineered From Bananas Fight Many Deadly Viruses? University of Michigan Health System Study     10/27/2015

Press Releases
BiondVax Pharmaceuticals Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate Is Safe And Well Tolerated     11/29/2016
ADImmune Corporation Begins Shipments To EU And Phase III Trial In Europe     11/23/2016
Highly Pathogenic Bird Flu Spreading Across Europe And Asia; BiondVax Pharmaceuticals’s Universal Flu Vaccine Candidate Also Covers These Potential Pandemic Strains     11/22/2016
GlaxoSmithKline (GSK) Receives FDA Approval For Expanded Indication For Flulaval Quadrivalent (Influenza Vaccine) For Infants 6 Months And Older     11/21/2016
Acella Pharmaceuticals, LLC, Announces Approval Of A Generic Bromfed Antihistamine/Decongestant     10/28/2016
GlaxoSmithKline (GSK) Presents New Data For Shingles Candidate Vaccine At IDWeek Scientific Conference     10/27/2016
Protein Sciences Corporation Release: Flublok Influenza Vaccine Now Available In Mexico     10/26/2016
Eurocine Vaccines Announces Initiation Of Clinical Study Of The Nasal Influenza Vaccine Candidate Immunose FLU     10/25/2016
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine With Evidence Of Superior Efficacy* In Older Adults: Now In Canada     10/13/2016
Protein Sciences Corporation Release: FDA Approves Flublok Quadrivalent Influenza Vaccine     10/12/2016
DNAe Wins $51.9 Million BARDA Contract to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza     9/30/2016
Protein Sciences Corporation And Avanzcare Announce Licensing Of Influenza Vaccines For The MENA Region     9/22/2016
BiondVax Pharmaceuticals Phase 2b European Trial: Last Patient Out     9/21/2016
EpiVax To Advance Development Of Vaccine Against Stealth Flu Virus With New Funding     9/13/2016
SAb Biotherapeutics Receives $1.42 Million SBIR Grant To Advance Influenza Treatment     9/7/2016

//-->